Literature DB >> 21806496

Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.

M Elisa Lopes-Pires1, André L Casarin, Fernanda G Pereira-Cunha, Irene Lorand-Metze, Edson Antunes, Sisi Marcondes.   

Abstract

High production of reactive-oxygen species (ROS) by blood cells is involved in damage of the vascular endothelium and multiple organ dysfunction in sepsis. However, little is known about the intraplatelet ROS production in sepsis and its consequences on platelet reactivity. In this study, we evaluated whether the treatment of rats with lipopolysaccharide (LPS) affects platelet aggregation through intraplatelet ROS generation. Rats were injected with LPS (1 mg/kg, i.p.), and at 2 to 72 h thereafter, adenosine diphosphate (ADP) (3-10 µM) induced platelet aggregation was evaluated. Production of ROS in platelets was measured by flow cytometry using 2',7'-dichlorofluorescein diacetate (DCFH-DA). Treatment of rats with LPS time-dependently inhibited ADP-induced platelet aggregation within 72 h. The inhibitory effect of LPS on platelet aggregation was further increased when the platelets were incubated with polyethylene glycol-superoxide dismutase (PEG-SOD; 30 U/mL), polyethylene glycol-catalase (PEG-CAT; 1000 U/mL) or the NADPH oxidase inhibitor diphenyleneiodonium (DPI; 10 µM). The ROS production in non-stimulated platelets did not differ between control and LPS-treated rats. However, in ADP-activated platelets, generation of ROS was increased by 3.0- and 7.0-fold, as evaluated at 8 and 48 h after LPS injection, respectively. This increased ROS production was significantly reduced when platelets were incubated in vitro with DPI, PEG-SOD or PEG-CAT. In contrast, treatment of rats with N-acetylcysteine (150 mg/kg, i.p.) significantly reduced the inhibitory effect of LPS on platelet aggregation, and prevented the increased ROS production by in vivo LPS. Our results indicate that the increased intraplatelet ROS production does not contribute to the inhibitory effect of LPS on platelet aggregation; however, the maintenance of redox balance in LPS-treated rats is fundamental to restore the normal platelet response in these animals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806496     DOI: 10.3109/09537104.2011.603065

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  5 in total

Review 1.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

2.  PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis.

Authors:  M Elisa Lopes-Pires; Ana C Antunes Naime; Nádia J Almeida Cardelli; Débora J Anjos; Edson Antunes; Sisi Marcondes
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

3.  Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis.

Authors:  Michael Adamzik; Klaus Görlinger; Jürgen Peters; Matthias Hartmann
Journal:  Crit Care       Date:  2012-10-22       Impact factor: 9.097

4.  Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA2 signalling.

Authors:  Maria E Lopes Pires; Simon R Clarke; Sisi Marcondes; Jonathan M Gibbins
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

Review 5.  Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.

Authors:  Maria Elisa Lopes-Pires; Jéssica Oliveira Frade-Guanaes; Gregory J Quinlan
Journal:  Antioxidants (Basel)       Date:  2021-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.